Cargando…
Deficiency of histone lysine methyltransferase SETDB2 in hematopoietic cells promotes vascular inflammation and accelerates atherosclerosis
Epigenetic modifications of the genome, including DNA methylation, histone methylation/acetylation, and noncoding RNAs, have been reported to play a fundamental role in regulating immune response during the progression of atherosclerosis. SETDB2 is a member of the KMT1 family of lysine methyltransfe...
Autores principales: | Zhang, Xinbo, Sun, Jonathan, Canfrán-Duque, Alberto, Aryal, Binod, Tellides, George, Chang, Ying Ju, Suárez, Yajaira, Osborne, Timothy F., Fernández-Hernando, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262461/ https://www.ncbi.nlm.nih.gov/pubmed/34003795 http://dx.doi.org/10.1172/jci.insight.147984 |
Ejemplares similares
-
The SETDB1 histone methyltransferase is recurrently amplified in and accelerates melanoma
por: Ceol, Craig J., et al.
Publicado: (2011) -
The cytoplasmic fraction of the histone lysine methyltransferase Setdb1 is essential for embryonic stem cells
por: Rapone, Roberta, et al.
Publicado: (2023) -
Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer
por: Nishikawaji, Taketo, et al.
Publicado: (2016) -
Histone lysine methyltransferase SETDB2 suppresses NRF2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinoma
por: Yuan, Guangda, et al.
Publicado: (2022) -
Role of histone methyltransferase SETDB1 in regulation of tumourigenesis and immune response
por: Zhao, Zhipeng, et al.
Publicado: (2022)